HomeHKMPY • OTCMKTS
add
Hikma Pharmaceuticals Plc
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 779.00M | 7.60% |
Operating expense | 226.50M | 20.48% |
Net income | 66.50M | 125.42% |
Net profit margin | 8.54 | 109.83% |
Earnings per share | — | — |
EBITDA | 144.00M | -17.95% |
Effective tax rate | 20.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 213.00M | -6.99% |
Total assets | 5.13B | 9.68% |
Total liabilities | 2.81B | 13.80% |
Total equity | 2.32B | — |
Shares outstanding | 220.43M | — |
Price to book | 4.89 | — |
Return on assets | 5.02% | — |
Return on capital | 7.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 66.50M | 125.42% |
Cash from operations | 183.00M | -5.18% |
Cash from investing | -137.50M | -28.50% |
Cash from financing | -68.00M | 43.10% |
Net change in cash | -24.00M | 28.36% |
Free cash flow | 44.69M | -41.73% |
About
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Founded
1978
Website
Employees
9,500
